Earlier this week, Life Biosciences, a biotech company focused on reversing age-related diseases, announced that it had dosed its first volunteer. A person with glaucoma has had an experimental treatment injected straight into their eyeball. The idea is to try to treat the disease—which can cause vision loss—by regenerating healthy nerves in the eye. But…
Most mergers don’t fail on strategy — they fail in the first 100 days when leaders avoid hard decisions around culture, ownership and what the new company will actually become.
As Ted Lasso returns this summer, its leadership lessons offer founders a practical blueprint for leading under pressure with clarity, trust and impact.
Most mergers don’t fail on strategy — they fail in the first 100 days when leaders avoid hard decisions around culture, ownership and what the new company will actually become.
As Ted Lasso returns this summer, its leadership lessons offer founders a practical blueprint for leading under pressure with clarity, trust and impact.